Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of GSK's DTPa/Hib Vaccine in Chinese Infants
NCT00379977Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of diphtheria toxoid + tetanus toxoid + acellular pertussis vaccine + haemophilus influenzae type b conjugate vaccine in diphtheria, Tetanus, pertussis, Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Sep 2006; status: completed.
02
Drugs
diphtheria toxoid + tetanus toxoid + acellular pertussis vaccine + haemophilus influenzae type b conjugate vaccine
03
Conditions
diphtheriaTetanuspertussisHaemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00379977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00379977.